US new drug price exceeds $200,000 median in 2022

Read more

Budget 2023: What industries look forward to

Read more

Lupin launches novel fixed-dose triple drug combination Difizma DPI to treat inadequately controlled asthma

Read more

USFDA allows abortion pills to be sold at retail pharmacies

Read more

Sanofi sees decision on Zantac dispute with Boehringer in Q1

Read more

Indian scientists discover new anti-cancer agent showing huge promise

Read more

Geron’s blood cancer drug succeeds in late-stage study, shares surge

Read more

How data is transforming business for pharma industry

Read more

Hikma Pharma launches Xyrem’s generic in US

Read more

Granules partners with Greenko ZeroC to enable carbon-free energy and green molecule

Read more